Recent intervention trials in hypertension initiated in Sweden HOT, CAPPP and others

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 507-515

  Hansson, Lennart ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

CAPPP; HOT; Hypertension intervention trials; SCOPE; STOP Hypertension 2

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE;

CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESEARCH; HUMAN; HYPERTENSION; SWEDEN;

EID: 0032769154     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909060984     Document Type: Conference Paper

References (18)

1. Hamilton M, Thompson EN, Wisniewski TKM. The role of blood pressure control in preventing complications in hypertension. Lancet 1964;1:235-238.
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA 1967;202:1028-1034.
3. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-1152.
4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach N H, Eberlein K A, Godwin J, Qizilbash N, Taylor J O, Hennekens C H. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: over-view of randomised drug trials in their epidemiological context. Lancet 1990;335:827-838.
5. SHEP Cooperative Research Group. Prevention of stroke by hypertensive drug therapy in older persons with isolated systolic hypertension : Final results of the systolic hypertension in the elderly program. JAMA 1991 ; 265 : 3255-3264.
6. Dahlöf B, Lindholm L H, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-1285.
7. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Brit Med J 1992;304:405-412.
8. Gong L, Zhang W, Zhu Y, Zhu J, 11 collaborating centres in the Shanghai area, Kong D, Pagé V, Ghadirian P, DeLorier J, Hamet P. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996;14:1237-1245.
9. Staessen J A, Fagard R, Thijs L, Celis H, Arabidze G G, Birkenhäger W H, Bulpitt C J, de Leeuw P W, Dollery C T, Fletcher A E, Forette F, Leonetti G, Nachev C, O'Brien E T, Rosenfeld J, Rodicio J L, Tuomilehto J, Zanchetti A, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.
10. Liu L, Wang JG, Gong L, Liu G, Staessen JA for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens1998 (accepted for publication).
11. Hansson L, Zanchetti A for the HOT Study Group. The Hypertension Optimal Treatment (HOT) Study - Patient characteristics: randomization, risk profiles, and early blood pressure results. BLOOD PRESSURE 1994;3:322-327.
12. Hansson L, Hedner T, Lindholm L, Niklason A, Loumanmäki K, Niskanen L, Lanke J, Dahlöf B, de Faire U, Mörlin C, Karlberg B E, Wester P O, Björck J-E for the CAPPP Study Group. The Captopril Prevention Project (CAPPP) in hypertension - Baseline data and current status. BLOOD PRESSURE 1997;6:365-367.
13. Lindholm L H, Hansson L, Dahlöf B, Ekbom T, Hedner T, De Faire U, Scherstén B, Wester P-O. The Swedish trial in Old Patients with Hypertension (STOP-Hypertension-2): a progress report. Blood Pressure 1996;5:300-304.
14. The NORDIL Study Group. The Nordic Diltiazem Study. An intervention study in hypertension comparing calcium antagonist based treatment with conventional therapy. BLOOD PRESSURE 1993;2:312-321.
15. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Ménard J, Julius S, Rahn KH, Wedel H, Westerling S for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-1762.
16. Hansson L, Hedner T, Dahlöf B. Prospective Randomized Open Blinded End-point (PROBE) Study: A novel design for intervention trials. BLOOD PRESSURE 1992;1:113-119.
17. Wiklund I, Hailing K, Rydén-Bergsten T, Fletcher A on behalf of the HOT Study Group. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal treatment (HOT) Study. Blood Pressure 1997;6:357-364.
18. Hansson L, Lindholm L H, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg B E, Wester P O, Björck J-E for the CAPPP Study Group. Principal results of the Captopril Prevention Project (CAPPP). Effect of Angiotensin Converting Enzyme Inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. Lancet 1998 (accepted for publication).